Vimarsana
Biggest News Aggregation in the World

Her2 Amplified News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Her2 Amplified. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Her2 Amplified Today - Breaking & Trending Today

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer - Vimarsana News

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer

Published: June 3, 2023

Zanidatamab generated responses in patients with HER2-amplified, locally advanced, unresectable or metastatic biliary tract cancer who were previously treated with gemcitabine.

Source: onclive.com
Related Topics:
United StatesDepartment Of Gastrointestinal Medical OncologyDepartment Of Investigational TherapeuticsUniversity Of Texas Md Anderson Cancer CenterGastrointestinal Medical OncologyInvestigational TherapeuticsCancer CenterHer2 AmplifiedBiliary Tract CancerHerizon Btc 01Asco Annual Meeting
Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC - Vimarsana News

Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC

Published: April 10, 2023

Micheal Foote, MD, discusses the use of tucatinib plus trastuzumab compared with chemotherapy in the management of HER2-amplified metastatic colorectal cancer.

Source: onclive.com
Related Topics:
Michael FooteMemorial Sloan Kettering Cancer CenterMetastatic Colorectal CancerHer2 AmplifiedMetastatic Colorectal CancerMountaineer Study